🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study was to evaluate the safe and effective u...
Status
Completed
Location
Research Site
Start Date
2009-01
Trial ID
NCT00828204
The purpose of this study is to characterize the pharmacokinetic (PK) profi...
Status
Completed
Location
Research Site
Start Date
2012-06
Trial ID
NCT01610310
To evaluate the efficacy and safety of diazepam in the management of refrac...
Status
Completed
Location
Neurology Clinic, PC
Start Date
2006-01
Trial ID
NCT00319501
Treatments Being Tested
The purpose of this study is to learn about the effects of LY3074828 when g...
Status
Completed
Location
Covance Clinical Research Inc
Start Date
2019-03-27
Trial ID
NCT03886948
Treatments Being Tested
The primary objective of this study is to assess successful self-administra...
Status
Completed
Location
Kern Research Inc
Start Date
2024-04-02
Trial ID
NCT06224192
Treatments Being Tested
The purpose of this study is to evaluate bioavailability of lanadelumab (SH...
Status
Completed
Location
Clinical Pharmacology of Miami, LLC
Start Date
2019-05-14
Trial ID
NCT03918239
Treatments Being Tested
The purpose of this study is to look at the amount of the study drug, LY307...
Status
Completed
Location
Covance Clinical Research Inc
Start Date
2018-09-06
Trial ID
NCT03662100
Treatments Being Tested
800 adult first time kidney transplant recipients will be enrolled in the O...
Status
Recruiting
Location
University of Alabama School of Medicine: Transplantation
Start Date
2023-12-07
Trial ID
NCT05917522
Treatments Being Tested
To investigate and compare the pharmacokinetics, safety and tolerability of...
Status
Completed
Location
SGS Belgium NV Research Unit Stuivenberg
Start Date
2015-10-28
Trial ID
NCT02606903
Treatments Being Tested
The main purpose of this study is to compare the amount of mirikizumab that...
Status
Completed
Location
LabCorp CRU, Inc.
Start Date
2021-10-05
Trial ID
NCT05069896
Treatments Being Tested